BNP Measurement Reduces Resource Utilization for Patients With CHF Admitted Thorough the ED
NCT ID: NCT00587938
Last Updated: 2008-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2003-12-31
2005-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood Collection of Patient Presenting in the ED and Prescribed a BNP
NCT02614209
Utility of Serial BNP Levels in Emergency Department CHF
NCT00534066
B-type Natriuretic Peptide (BNP)-Guided Diagnostic Strategy in Intensive Care Unit (ICU) Patients With Respiratory Failure
NCT00130559
BNP Testing in Patients With SOB on Presentation to ED
NCT00163709
Exploring the Relationship Among BNP, Fluid Status and Acute Kidney Injury in Critically Ill Patients
NCT02095275
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
BNP level from protocol blood tests initiated in the ED, reported to ED physician prior to ED disposition.
No interventions assigned to this group
B
BNP level from protocol blood tests initiated in the ED, NOT reported to ED physician prior to ED disposition.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mayo Clinic
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raquel M Schears, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Alfredo L Clavell, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Lyle J Olsen, MD
Role: STUDY_CHAIR
Mayo Clinic
Paula J Santrach, MD
Role: STUDY_DIRECTOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Saint Marys Hospital, Mayo Clinic
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Schmidt TA, Salo D, Hughes JA, Abbott JT, Geiderman JM, Johnson CX, McClure KB, McKay MP, Razzak JA, Schears RM, Solomon RC; SAEM Ethics Committee. Confronting the ethical challenges to informed consent in emergency medicine research. Acad Emerg Med. 2004 Oct;11(10):1082-9. doi: 10.1197/j.aem.2004.05.028.
Clavell AL, Stingo AJ, Aarhus LL, Burnett JC Jr. Biological actions of brain natriuretic peptide in thoracic inferior vena caval constriction. Am J Physiol. 1993 Dec;265(6 Pt 2):R1416-22. doi: 10.1152/ajpregu.1993.265.6.R1416.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1780-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.